Search Within

Solid Tumor Oncology Division

  1. "Sloan Kettering Institute Faculty"
Formats
  1. Journal Article (946)
  2. Meeting Abstract (572)
  3. Book Section (20)
  4. Review (17)
  5. Conference Paper (15)
  6. Editorial (13)
  7. Book Whole (4)
  8. Research Letter (3)
  9. Correspondence (2)
  10. Guidelines (1)
  11. Miscellaneous (1)
Groups
  1. Department of Medicine (1594)
  2. Sloan Kettering Institute Faculty (1594)
  3. GSK Faculty (1347)
  4. Molecular Pharmacology and Chemistry Program Faculty (1037)
  5. Breast Medicine Service (607)
  6. Genitourinary Oncology Service (561)

More Groups

People
  1. Neal Rosen (424)
  2. Howard Scher (249)
  3. Steven Larson (236)
  4. Alan Houghton (194)
  5. David Solit (183)
  6. Jedd Wolchok (172)

More People

Years
  1. 2025 (8)
  2. 2024 (38)
  3. 2023 (37)
  4. 2022 (70)
  5. 2021 (57)
  6. 2020 (59)

More Years

Publications
  1. Cancer Research (188)
  2. Journal of Clinical Oncology (157)
  3. Clinical Cancer Research (106)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (78)
  5. Journal of Nuclear Medicine (62)
  6. Blood (46)

More Publications

Publishers
  1. American Association for Cancer Research (439)
  2. American Society of Clinical Oncology (162)
  3. Nature Publishing Group (133)
  4. Elsevier Inc. (95)
  5. Cell Press (69)
  6. Springer (65)

More Publishers

Results (1594)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Inhibition of PI3K-AKT signaling causes a FOXO-dependent induction of receptor tyrosine kinase expression and phosphorylation in cancer
    Meeting Abstract

    Chandarlapaty, S.; Sawai, A.; Rodrik-Outmezguine, V.; Scaltriti, M.; Serra, V.; Baselga, J.; Rosen, N.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Tumor entrained neutrophils inhibit seeding in the pre-metastatic lung
    Meeting Abstract

    Granot, Z.; Heneke, E.; Comen, E. A.; King, T. A.; Norton, L.; Benezra, R.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • The cytotoxicity of select neutrophils in cancer patients and the role of chemokines in Inducing neutrophil cytotoxicity
    Meeting Abstract

    Comen, E.; Granot, Z.; Norton, L.; Benezra, R.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I/II study in patients with metastatic HER2-amplified or triple-negative breast cancer
    Meeting Abstract

    Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Seidman, A. D.; Modi, S.; Dickler, M.; Drullinsky, P.; Syldor, A.; Sujata, P.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Monocytic CCR2+myeloid derived suppressor cells promote immune escape by limiting activated CD8 T cell infiltration into the tumor microenvironment
    Meeting Abstract

    Lesokhin, A.; Hohl, T.; Merghoub, T.; Hirschhorn-Cymerman, D.; Pamer, E. G.; Houghton, A. N.; Wolchok, J. D.
    Blood (2011)

    Fulltext@MSK | Save
  • Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer
    Journal Article

    Gucalp, A.; Sparano, J. A.; Caravelli, J.; Santamauro, J.; Patil, S.; Abbruzzi, A.; Pellegrino, C.; Bromberg, J.; Dang, C.; Theodoulou, M.; more...
    Clinical Breast Cancer (2011)

    Fulltext@MSK | Save
  • (124)I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET
    Journal Article

    O'Donoghue, J. A.; Smith-Jones, P. M.; Humm, J. L.; Ruan, S.; Pryma, D. A.; Jungbluth, A. A.; Divgi, C. R.; Carrasquillo, J. A.; Pandit-Taskar, N.; Fong, Y.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • Acinar cell carcinoma of the pancreas: New genetic and treatment insights into a rare malignancy
    Journal Article

    Lowery, M. A.; Klimstra, D. S.; Shia, J.; Yu, K. H.; Allen, P. J.; Brennan, M. F.; O'Reilly, E. M.
    The Oncologist (2011)

    Fulltext@MSK | Save
  • Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation
    Journal Article

    Chakravarty, D.; Santos, E.; Ryder, M.; Knauf, J. A.; Liao, X. H.; West, B. L.; Bollag, G.; Kolesnick, R.; Thin, T. H.; Rosen, N.; more...
    Journal of Clinical Investigation (2011)

    Fulltext@MSK | Save
  • RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
    Journal Article

    Poulikakos, P. I.; Persaud, Y.; Janakiraman, M.; Kong, X.; Ng, C.; Moriceau, G.; Shi, H.; Atefi, M.; Titz, B.; Gabay, M. T.; more...
    Nature (2011)

    Fulltext@MSK | Save